drugset / Trial / NCT04331405
Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury
Phase 1/2
Completed
20 enrolled
Sklifosovsky Institute of Emergency Care
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Study evaluates the safety and primary efficiency of systemic (i.v.) allogeneic human umbilical cord blood mononuclear cell infusions in patients with severe acute contusion spinal cord injury (ASIA A/B). 20 patients were included. Half of patients received cell therapy in addition to standard therapy, while the other half received standard therapy only.
Timeline
- Start
- 2013-03-18
- Primary completion
- 2018-03-21
- Completion
- 2018-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human Allogeneic Umbilical Cord Blood Mononuclear Cells | Unknown | 3e+08 cells | Intravenous |